Stroke Prevention in Nigeria 2 Trial — Stella

stellabeta Find trials matched to me Trial Match

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Stroke Prevention in Nigeria 2 Trial — Stella

Recruiting

Back to Sickle Cell Disease trials

Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.

Trial locations(2 sites)

Nigeria

Aminu Kano Teaching Hospital, Kano

Murtala Muhammad Specialist Hospital, Kano

Key details

Phase

Post-approval monitoring

Sponsor

Vanderbilt University Medical Center

Collaborators

Aminu Kano Teaching Hospital, Murtala Muhammed Specialist Hospital

Enrollment target

~220 participants

Started

August 2024

Primary completion

December 2029

Age range

5 Years – 12 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov